DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products ...

Dexcom (DXCM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on January 13. Analyst Mike Kratky from ...

Abbott Laboratories and DexCom said on Monday they have reached ... counter continuous glucose monitoring system in the U.S., the company said on Thursday, making it the second such device on ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Dexcom (DXCM – Research Report) on January 13 and set a price target of ...

Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...

Riverview Trust Co lifted its stake in DexCom by 100.4% in the third quarter. Riverview Trust Co now owns 463 shares of the medical device company’s stock valued at $31,000 after buying an ...